Improving care for older adults receiving radiation therapy
Official title: Improving Outcomes for Older Adults Undergoing Radiation Therapy: Prospective Cohort Study
Run by Icahn School of Medicine at Mount Sinai · NCT05721053 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to see how radiation therapy affects older adults with cancer to help improve their care and treatment experience.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05721053 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 65 and older with pathologically confirmed cancer who are receiving radiation therapy at Mount Sinai facilities.
✕Probably not a fit
Patients who are younger than 65 or do not have a confirmed cancer diagnosis will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance the healthcare experience for individuals aged 65 and older who are undergoing radiation therapy for cancer. It will assess patients' ability to complete their treatment, monitor changes in daily functioning, and evaluate self-reported side effects through surveys and assessments at multiple timepoints: before treatment, at the end of treatment, and during follow-ups at 1, 3, and 6 months. The findings will provide valuable insights for radiation oncologists to improve future patient care.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment outcomes and quality of life for older adults undergoing radiation therapy.
How similar studies have gone: While there may be similar studies focusing on older adults and cancer treatment, this specific approach to improving radiation therapy outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient must be ≥ 65 years * Patient must have pathologically confirmed cancer * Patient must have the ability to provide informed consent, or have a legally authorized representative (LAR) present to provide informed consent on the participant's behalf * Must be radiation oncology patient at Mount Sinai Hospital, Mount Sinai Downtown, or Mount Sinai West. Exclusion Criteria: * There is no exclusion criteria
Where it's running
-
One Gustave L Levy Place
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Kavita Dharmarajan, MD, MSc — Icahn School of Medicine at Mount Sinai
- Study coordinator: Vanessa Jimenez
- Email: vanessa.jimenez@mountsinai.org
- Phone: (212) 824-7325
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FAPI-guided radiotherapy with cadonilimab plus chemo for colorectal cancer limited to the peritoneum
Aims to see if adding targeted radiotherapy and cadonilimab immunotherapy to standard second-line chemotherapy helps adults with colorectal cancer that’s spread only to the peritoneum.
-
Pelvic ultra-hypofractionated radiotherapy after surgery for high-risk endometrial cancer
This trial tests whether giving 27.5 Gy in five sessions of pelvic radiotherapy after surgery is safe and feasible for high-risk endometrial cancer patients.
-
Radiation-related heart damage in locally advanced NSCLC tested with PET-CT
This study tests whether PET-CT imaging with 18F-Flurpiridaz can detect early radiation-related heart damage in adults with locally advanced non-small cell lung cancer receiving standard chemoradiation.
-
Seeing what cancer patients eat during radiation treatment using a mobile food diary
This study tests whether patients undergoing radiation therapy can consistently use a mobile food diary app to log their daily meals.
-
CAIX PET/CT–guided radiation for clear cell kidney cancer
This trial will try using CAIX-targeted PET/CT scans plus FDG PET/CT to guide focused stereotactic radiation alongside standard targeted therapy and anti‑PD‑1 immunotherapy for adults with recurrent or metastatic clear cell kidney cancer.
-
Radiation therapy options compared for newly diagnosed gynecologic cancers
This study tests whether proton therapy works as well as conventional photon therapy for endometrial and cervical cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.